Option 1: IMD’s Pathology Collaborator Model: Going beyond TC/PC by enhancing business opportunities. This model offers a Pathology Group tangible benefits that collaborate with an aligned purpose.
Option 2: IMD’s Shareholder-Equity Model: This model incorporates all the elements of the Collaborator Model. Additionally, it is positioned to add strength to the independence that is key to the success and longevity of Pathology Groups.
If you are interested to know the details of either model, please contact us and we will have one of our experts contact you within 24 hours.